Literature DB >> 3414852

Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal.

J H Mendelson1, S K Teoh, U Lange, N K Mello, R Weiss, A Skupny, J Ellingboe.   

Abstract

Plasma luteinizing hormone (LH), prolactin, testosterone, and cortisol levels were determined in 16 patients after hospital admission for cocaine abuse, during the course of 4 weeks of hospitalization, and before discharge. Hyperprolactinemia was found at admission (mean +/- SD, 27.5 +/- 10.2 ng/ml) and persisted until discharge (mean +/- SD, 28.7 +/- 10.8 ng/ml). Plasma LH, testosterone, and cortisol levels were within normal limits. These findings suggest that persistent elevation of plasma prolactin levels after cocaine withdrawal may reflect a chronic cocaine-induced derangement in neural dopaminergic regulatory systems.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3414852     DOI: 10.1176/ajp.145.9.1094

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  9 in total

Review 1.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

2.  Plasma progesterone levels and cocaine-seeking in freely cycling female rats across the estrous cycle.

Authors:  Matthew W Feltenstein; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2007-01-19       Impact factor: 4.492

3.  Elevated plasma prolactin in abstinent methamphetamine-dependent subjects.

Authors:  Todd Zorick; Mark A Mandelkern; Buyean Lee; Ma-Li Wong; Karen Miotto; Jon Shabazian; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2010-12-10       Impact factor: 3.829

4.  Psychoticism and neuroticism predict cocaine dependence and future cocaine use via different mechanisms.

Authors:  James J Prisciandaro; Aimee L McRae-Clark; Megan M Moran-Santa Maria; Karen J Hartwell; Kathleen T Brady
Journal:  Drug Alcohol Depend       Date:  2011-02-08       Impact factor: 4.492

5.  Opioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men.

Authors:  Nathalie V Goletiani; Jack H Mendelson; Michelle B Sholar; Arthur J Siegel; Nancy K Mello
Journal:  Pharmacol Biochem Behav       Date:  2008-09-18       Impact factor: 3.533

6.  Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals.

Authors:  Kathleen T Brady; Aimee L McRae; Megan M Moran-Santa Maria; Stacia M DeSantis; Annie N Simpson; Angela E Waldrop; Sudie E Back; Mary Jeanne Kreek
Journal:  Arch Gen Psychiatry       Date:  2009-04

7.  Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence.

Authors:  Ashwin A Patkar; Paolo Mannelli; Kenneth M Certa; Kathleen Peindl; Heather Murray; Michael J Vergare; Wade H Berrettini
Journal:  Psychopharmacology (Berl)       Date:  2004-04-03       Impact factor: 4.530

8.  Daily cocaine self-administration under long-access conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats.

Authors:  John R Mantsch; William E Cullinan; Lee C Tang; David A Baker; Eric S Katz; Michael A Hoks; Dana R Ziegler
Journal:  Brain Res       Date:  2007-07-14       Impact factor: 3.252

9.  Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence.

Authors:  Brian Reed; Eduardo R Butelman; Rebecca S Fry; Rachel Kimani; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.